Capillary Technologies India Ltd.

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) and the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, (‘SEBI (SBEBSE)’),as amended from time to time, Capillary Technologies India has informed that the Nomination and Remuneration Committee (NRC) of the Board of Directors of the Company granted 7,45,537 stock options of the Company of Face Value of ?2 each, to eligible employees of the Company under the ESOP Plan 2021, vide circular resolution approved on July 01, 2026. The details pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January, 2026, as amended from time to time (‘SEBI Circulars’), with respect to the aforesaid grant of ESOPs is enclosed as an Annexure-I. The above information is also available on the Company’s website at https://www.capillarytech.com/investors/shareholder-information/corporateannouncements/.

The above information is a part of company’s filings submitted to BSE.